LingyiMed

Hangzhou, China · Founded 2021 · Privately Held (backing)

Developer of biotechnology materials designed for pharmaceutical research and clinical application purposes. LingyiMed is based in Hangzhou, China and was founded in 2021. It has raised $29.4 million.

Last price · $/share
—
Implied valuation
—
Total raised
$29.4M
Last round
—

Who backs LingyiMed?

11 investors
InvestorType
HSG (Hong Kong)Other
Shenzhen Yifeng Investment Management EnterpriseVenture capital
Hangzhou CapitalOther
Holley GroupOther
Jingjie InvestmentOther
Transfar CapitalOther
HJ-InvestmentOther
Gisway—
Hangzhou Huaiji Investment—
MPC (Beijing)—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

LingyiMed investors

11 investors are on record for LingyiMed, including HSG (Hong Kong), Shenzhen Yifeng Investment Management Enterprise, Hangzhou Capital and Holley Group.

Free account
More of LingyiMed with a free account
  • ·The complete investor list: 11 names
  • ·Watch LingyiMed: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like LingyiMed. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View